Abstract
Following publication of the original article [1], the authors corrected the declared corresponding author from Huiqin Liu to Qi He. Qi He was the one who put forward the idea of the article; and is the general director of the whole project. The original article [1] has been corrected.
Cite
CITATION STYLE
Liu, H., Wang, Y., & He, Q. (2023, December 1). Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China (Health Economics Review, (2022), 12, 1, (66), 10.1186/s13561-022-00410-x). Health Economics Review. BioMed Central Ltd. https://doi.org/10.1186/s13561-023-00419-w
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
